Spots Global Cancer Trial Database for Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer
Official Title: A Randomized, Controlled Trial to Evaluate the Effects of Nadroparin on Survival and Disease Progression in Patients With Advanced Malignancies of the Lung, Pancreas, or Prostate
Study ID: NCT00312013
Conditions
Interventions
Study Description
Brief Summary: This study will evaluate the effects of nadroparin on survival and disease progression in patients with hormone-refractory prostate cancer (HRPC), locally advanced pancreatic cancer or non-small-cell lung carcinoma (NSCLC).
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GSK Investigational Site, Aalst, , Belgium
GSK Investigational Site, Antwerpen, , Belgium
GSK Investigational Site, Brasschaat, , Belgium
GSK Investigational Site, Bruxelles, , Belgium
GSK Investigational Site, Bruxelles, , Belgium
GSK Investigational Site, Liège, , Belgium
GSK Investigational Site, Roeselare, , Belgium
GSK Investigational Site, Toronto, Ontario, Canada
GSK Investigational Site, Brno, , Czech Republic
GSK Investigational Site, Praha 2, , Czech Republic
GSK Investigational Site, Praha 5, , Czech Republic
GSK Investigational Site, Praha 5, , Czech Republic
GSK Investigational Site, Praha 8, , Czech Republic
GSK Investigational Site, Pribram, , Czech Republic
GSK Investigational Site, Bethune Cedex, , France
GSK Investigational Site, Clermont Ferrand, , France
GSK Investigational Site, Lille, , France
GSK Investigational Site, Lyon, , France
GSK Investigational Site, Marseille, , France
GSK Investigational Site, Paris Cedex 13, , France
GSK Investigational Site, Paris Cedex 15, , France
GSK Investigational Site, Paris, , France
GSK Investigational Site, Paris, , France
GSK Investigational Site, Pierre Benite, , France
GSK Investigational Site, Saint-Priest en Jarez, , France
GSK Investigational Site, Strasbourg, , France
GSK Investigational Site, Freiburg, Baden-Wuerttemberg, Germany
GSK Investigational Site, Heidelberg, Baden-Wuerttemberg, Germany
GSK Investigational Site, Mannheim, Baden-Wuerttemberg, Germany
GSK Investigational Site, Augsburg, Bayern, Germany
GSK Investigational Site, Ebensfeld, Bayern, Germany
GSK Investigational Site, Planegg, Bayern, Germany
GSK Investigational Site, Fulda, Hessen, Germany
GSK Investigational Site, Giessen, Hessen, Germany
GSK Investigational Site, Greifenstein, Hessen, Germany
GSK Investigational Site, Hannover, Niedersachsen, Germany
GSK Investigational Site, Duesseldorf, Nordrhein-Westfalen, Germany
GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany
GSK Investigational Site, Herne, Nordrhein-Westfalen, Germany
GSK Investigational Site, Koeln, Nordrhein-Westfalen, Germany
GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany
GSK Investigational Site, Halle, Sachsen-Anhalt, Germany
GSK Investigational Site, Magdeburg, Sachsen-Anhalt, Germany
GSK Investigational Site, Bad Berka, Thueringen, Germany
GSK Investigational Site, Berlin, , Germany
GSK Investigational Site, Berlin, , Germany
GSK Investigational Site, Bremen, , Germany
GSK Investigational Site, Hamburg, , Germany
GSK Investigational Site, Hamburg, , Germany
GSK Investigational Site, Budapest, , Hungary
GSK Investigational Site, Budapest, , Hungary
GSK Investigational Site, Budapest, , Hungary
GSK Investigational Site, Győr, , Hungary
GSK Investigational Site, Törökbálint, , Hungary
GSK Investigational Site, Chieti Scalo, Abruzzo, Italy
GSK Investigational Site, Genova, Liguria, Italy
GSK Investigational Site, Bergamo, Lombardia, Italy
GSK Investigational Site, Milano, Lombardia, Italy
GSK Investigational Site, Milano, Lombardia, Italy
GSK Investigational Site, Pavia, Lombardia, Italy
GSK Investigational Site, Campobasso, Molise, Italy
GSK Investigational Site, Firenze, Toscana, Italy
GSK Investigational Site, Padova, Veneto, Italy
GSK Investigational Site, Almelo, , Netherlands
GSK Investigational Site, Amsterdam, , Netherlands
GSK Investigational Site, Amsterdam, , Netherlands
GSK Investigational Site, Amsterdam, , Netherlands
GSK Investigational Site, Breda, , Netherlands
GSK Investigational Site, Delft, , Netherlands
GSK Investigational Site, Den Haag, , Netherlands
GSK Investigational Site, Eindhoven, , Netherlands
GSK Investigational Site, Enschede, , Netherlands
GSK Investigational Site, Nieuwegein, , Netherlands
GSK Investigational Site, Nijmegen, , Netherlands
GSK Investigational Site, Rotterdam, , Netherlands
GSK Investigational Site, Sittard, , Netherlands
GSK Investigational Site, Winterswijk, , Netherlands
GSK Investigational Site, Zwolle, , Netherlands
GSK Investigational Site, Bialystok, , Poland
GSK Investigational Site, Krakow, , Poland
GSK Investigational Site, Lubin, , Poland
GSK Investigational Site, Olsztyn, , Poland
GSK Investigational Site, Olsztyn, , Poland
GSK Investigational Site, Warszawa, , Poland
GSK Investigational Site, Arkhangelsk, , Russian Federation
GSK Investigational Site, Kazan, , Russian Federation
GSK Investigational Site, Kirov, , Russian Federation
GSK Investigational Site, Moscow, , Russian Federation
GSK Investigational Site, Omsk, , Russian Federation
GSK Investigational Site, Orenburg, , Russian Federation
GSK Investigational Site, Samara, , Russian Federation
GSK Investigational Site, St. Petersburg, , Russian Federation
GSK Investigational Site, Voronezh, , Russian Federation
GSK Investigational Site, Golnik, , Slovenia
GSK Investigational Site, Ljubljana, , Slovenia
Contact Details
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
